Experience of therapy for bacterial vaginosis


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To study the efficiency of using clindacin B prolong for the treatment of bacterial vaginosis (BV) concurrent with nonspecific vaginitis in non-pregnant women. Subjects and methods. The investigation enrolled 32 non-pregnant women of reproductive age (mean age, 27.3+0.7 years), who were diagnosed with BV concurrent with nonspecific vaginitis. All the patients were treated with clindacin B prolong at an intravaginal dose of 5.0 g overnight for 3 days. Results. After treatment, all the examinees were observed to have clinical improvements and a significant decrease in opportunistic microorganisms. Conclusion. Clindacin B prolong vaginal cream is quite effective in treating BV associated with nonspecific vulvovaginitis.

Full Text

Restricted Access

About the authors

Larisa Vladimirovna Lavrova

Regional Clinical Hospital, Ryazan

obstetrician-gynecologist, head of the women’s consultation

Natalia Ivanovna Dyagileva

Regional Clinical Hospital, Ryazan

obstetrician-gynecologist

Ekaterina Evgenevna Karpova

Regional Clinical Hospital, Ryazan

obstetrician-gynecologist

References

  1. Spiegel C.A. Bacterial vaginosis. Rev. Med. Microbiol.2002; 13(2): 43-51.
  2. Кира Е.Ф. Бактериальный вагиноз. Практическое руководство. СПб.; 2001. [Kira E.F. Bacterial vaginosis. Practical guidance. St. Petersburg; 2001. (in Russian)]
  3. Fredericks D.N., Fiedler T.L., Marrazzo J.M. Molecular identification of bacteria associated with bacterial vaginosis. N. Engl. J. Med. 2005; 353(18): 1889-911.
  4. Маклецова С.А., Рябинкина Т.С. Бактериальный вагиноз: видимые горизонты проблемы и перспективы диагностики и лечения бактериального вагиноза: что говорят эксперты. Status Praesens. 2014; 3: 47-57. [Makletsova S.A., Ryabinkina T.S. Bacterial vaginosis: the visible horizons of the problem and the prospects for diagnosis and treatment of bacterial vaginosis: what the experts say. Status Praesens. 2014; 3: 47-57. (in Russian)]
  5. Савичева А.М., Рыбина Е.В., Ипатова И.Д. В «дружной» компании. Бактериальный вагиноз и смешанные вагинальные инфекции: возможно ли одно без другого? StatusPraesens. Гинекология, акушерство, бес плодный брак. 2014; 6: 39-46. [Savicheva A.M., Ryibina E.V., Ipatova I.D. In a „friendly” company. Bacterial vaginosis and mixed vaginal infections: is one possible without the other? StatusPraesens. Ginekologiya, akusherstvo, besplodnyiy brak. 2014; 6: 39-46. (in Russian)]
  6. Фофанова И.Ю., Прилепская В.Н. Рациональные подходы к терапии бактериального вагиноза. Гинекология. 2013; 15(5): 28-31. [Fofanova I.Yu., Prilepskaya V.N. Rational approaches to therapy of bacterial vaginosis. Ginekologiya. 2013; 15(5): 28-31. (in Russian)]
  7. Тютюнник В.Л. Патогенез, диагностика и методы лечения бактериального вагиноза. Фарматека. 2005; 2: 20-4. [Tyutyunnik V.L. Pathogenesis, diagnosis and treatment of bacterial vaginosis. Farmateka. 2005; 2: 20-4. (in Russian)]
  8. Савченко Т.Н., Крамарь В.С. Микроэкология влагалища при дисбактериозе. Международный журнал прикладных и фундаментальных исследований. 2011; 5: 109-10. [Savchenko T.N., Kramar V.S. Microecology of the vagina with dysbiosis. Mezhdunarodnyiy zhurnal prikladnyih i fundamentalnyih issledovaniy. 2011; 5: 109-10. (in Russian)]
  9. Страчунский Л.С. Антибактериальная терапия. Практическое руководство. М.; 2000. [Strachunskiy L.S. Antibacterial therapy. Practical guidance. Moscow; 2000. (in Russian)]

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies